TUDOR INVESTMENT CORP ET AL - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 123 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$181,671
-18.1%
10,405
+0.4%
0.00%
-66.7%
Q2 2023$221,811
-58.6%
10,365
+0.4%
0.00%
-75.0%
Q3 2022$536,000
-5.5%
10,327
-13.8%
0.01%
-20.0%
Q2 2022$567,000
-72.8%
11,986
-59.0%
0.02%
-69.4%
Q1 2022$2,082,000
+3.3%
29,254
+8.6%
0.05%
+44.1%
Q4 2021$2,015,000
+348.8%
26,946
+241.2%
0.03%
+385.7%
Q3 2021$449,000
-80.1%
7,897
-84.6%
0.01%
-83.7%
Q2 2021$2,261,000
+129.1%
51,376
+156.7%
0.04%
+115.0%
Q1 2021$987,000
-46.8%
20,011
-54.6%
0.02%
-61.5%
Q4 2020$1,856,000
+229.1%
44,086
+292.7%
0.05%
+85.7%
Q2 2020$564,000
+169.9%
11,227
+93.5%
0.03%
+366.7%
Q2 2017$209,000
-43.1%
5,802
-51.3%
0.01%
-45.5%
Q1 2017$367,000
-29.2%
11,902
-23.1%
0.01%
-15.4%
Q4 2016$518,000
+72.7%
15,470
+57.9%
0.01%
+30.0%
Q1 2015$300,000
-34.4%
9,800
+9.0%
0.01%
-37.5%
Q4 2014$457,000
-43.9%
8,987
-56.4%
0.02%
-44.8%
Q3 2014$815,00020,5960.03%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders